The unusual structure of Ruminococcin C1 antimicrobial peptide confers clinical properties - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Proceedings of the National Academy of Sciences of the United States of America Année : 2020

The unusual structure of Ruminococcin C1 antimicrobial peptide confers clinical properties

Steve Chiumento
  • Fonction : Auteur
Christian Basset
  • Fonction : Auteur
Yohann Couté
Olga Iranzo
Marc Maresca
Mohamed Atta
  • Fonction : Auteur
Victor Duarte
  • Fonction : Auteur correspondant
  • PersonId : 860137

Connectez-vous pour contacter l'auteur

Résumé

The emergence of superbugs developing resistance to antibiotics and the resurgence of microbial infections have led scientists to start an antimicrobial arms race. In this context, we have previously identified an active RiPP, the Ruminococcin C1, naturally produced by Ruminococcus gnavus E1, a symbiont of the healthy human intestinal microbiota. This RiPP, subclassified as a sactipeptide, requires the host digestive system to become active against pathogenic Clostridia and multidrug-resistant strains. Here we report its unique compact structure on the basis of four intramolecular thioether bridges with reversed stereochemistry introduced posttranslationally by a specific radical-SAM sactisynthase. This structure confers to the Ruminococcin C1 important clinical properties including stability to digestive conditions and physicochemical treatments, a higher affinity for bacteria than simulated intestinal epithelium, a valuable activity at therapeutic doses on a range of clinical pathogens, mediated by energy resources disruption, and finally safety for human gut tissues.
Fichier principal
Vignette du fichier
Combined manuscript.pdf (2.55 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-02920462 , version 1 (08-12-2020)

Identifiants

Citer

Clarisse Roblin, Steve Chiumento, Olivier Bornet, Matthieu Nouailler, Christina S. Müller, et al.. The unusual structure of Ruminococcin C1 antimicrobial peptide confers clinical properties. Proceedings of the National Academy of Sciences of the United States of America, 2020, 120 (13), pp.e2302405120. ⟨10.1073/pnas.2302405120⟩. ⟨hal-02920462⟩
344 Consultations
131 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More